Equities analysts expect Alcentra Capital Corp. (NASDAQ:ABDC) to post $8.81 million in sales for the current quarter, Zacks reports. Six analysts have issued estimates for Alcentra Capital Corp.’s earnings, with the lowest sales estimate coming in at $8.10 million and the highest estimate coming in at $9.35 million. Alcentra Capital Corp. posted sales of $9.12 million during the same quarter last year, which would indicate a negative year over year growth rate of 3.4%. The company is expected to announce its next quarterly earnings results on Thursday, November 2nd.

According to Zacks, analysts expect that Alcentra Capital Corp. will report full-year sales of $8.81 million for the current year, with estimates ranging from $32.80 million to $37.19 million. For the next fiscal year, analysts anticipate that the firm will post sales of $38.51 million per share, with estimates ranging from $34.90 million to $40.12 million. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that follow Alcentra Capital Corp..

Several equities research analysts recently commented on ABDC shares. DA Davidson started coverage on Alcentra Capital Corp. in a research note on Wednesday, July 5th. They set a “buy” rating and a $15.00 target price for the company. TheStreet cut Alcentra Capital Corp. from a “b” rating to a “c+” rating in a research note on Monday, July 24th. Keefe, Bruyette & Woods set a $13.00 target price on Alcentra Capital Corp. and gave the stock a “hold” rating in a research note on Sunday, August 6th. Finally, Raymond James Financial, Inc. cut Alcentra Capital Corp. from a “strong-buy” rating to an “outperform” rating and decreased their target price for the stock from $16.00 to $14.00 in a research note on Monday, July 17th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Alcentra Capital Corp. presently has a consensus rating of “Hold” and a consensus target price of $13.50.

COPYRIGHT VIOLATION NOTICE: “$8.81 Million in Sales Expected for Alcentra Capital Corp. (ABDC) This Quarter” was posted by Watch List News and is owned by of Watch List News. If you are reading this article on another website, it was illegally copied and republished in violation of international trademark and copyright laws. The original version of this article can be read at https://www.watchlistnews.com/8-81-million-in-sales-expected-for-alcentra-capital-corp-abdc-this-quarter/1476755.html.

In other Alcentra Capital Corp. news, major shareholder Of New York Mellon Corp Bank sold 1,691,839 shares of the stock in a transaction that occurred on Monday, May 22nd. The stock was sold at an average price of $13.13, for a total value of $22,213,846.07. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Steven H. Reiff purchased 11,668 shares of the business’s stock in a transaction on Monday, August 7th. The stock was purchased at an average price of $10.72 per share, for a total transaction of $125,080.96. Following the acquisition, the director now owns 7,000 shares of the company’s stock, valued at approximately $75,040. The disclosure for this purchase can be found here. 4.96% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in ABDC. Bank of Montreal Can purchased a new position in shares of Alcentra Capital Corp. during the second quarter valued at about $163,000. Oppenheimer & Co. Inc. raised its position in shares of Alcentra Capital Corp. by 4.4% in the second quarter. Oppenheimer & Co. Inc. now owns 13,098 shares of the asset manager’s stock valued at $178,000 after buying an additional 550 shares during the last quarter. Creative Planning raised its position in shares of Alcentra Capital Corp. by 2.9% in the first quarter. Creative Planning now owns 20,570 shares of the asset manager’s stock valued at $283,000 after buying an additional 570 shares during the last quarter. Wells Fargo & Company MN raised its position in shares of Alcentra Capital Corp. by 4.9% in the first quarter. Wells Fargo & Company MN now owns 28,835 shares of the asset manager’s stock valued at $396,000 after buying an additional 1,354 shares during the last quarter. Finally, Mackenzie Financial Corp purchased a new position in shares of Alcentra Capital Corp. during the first quarter valued at about $491,000. Institutional investors and hedge funds own 43.52% of the company’s stock.

Alcentra Capital Corp. (NASDAQ:ABDC) opened at 10.74 on Friday. Alcentra Capital Corp. has a 52-week low of $10.20 and a 52-week high of $14.73. The stock’s 50 day moving average price is $12.45 and its 200 day moving average price is $13.12.

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 5th. Shareholders of record on Saturday, September 30th will be issued a $0.34 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.36 annualized dividend and a yield of 12.66%. Alcentra Capital Corp.’s payout ratio is currently -1,700.00%.

About Alcentra Capital Corp.

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Get a free copy of the Zacks research report on Alcentra Capital Corp. (ABDC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Alcentra Capital Corp. (NASDAQ:ABDC)

Receive News & Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.